Skip to main content

IGM Biosciences, Inc.

IGMSDelisted Aug 14, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001496323

IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.

Holders of 5% or more of IGMS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of IGM Biosciences, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of IGMS
HolderLatest formStakeChangeFirst filedLatest filingFiling
Price T Rowe Associates Inc13G/A10.50%3.57M shares+10.30 ppfrom 0.20%Feb 7, 20252 filingsFeb 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

7 Schedule 13D and 13G filings on IGM Biosciences, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on IGMS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 13, 20254:44 PM ETGlazer Capital, LLCand 1 other13G/A0.00%0 shares−7.30 ppfrom 7.30%Below 5%Sep 30, 2025SEC
Aug 18, 20255:52 PM ETBaker Bros. Advisors LPand 3 others13D/A0.00%0 shares–Below 5%Aug 14, 2025SEC
Aug 18, 20254:31 PM ETTopsoe Holding A/Sand 6 others13D/A0.00%0 shares–Below 5%Aug 14, 2025SEC
Aug 15, 20255:01 PM ETRedmile Group, LLCand 1 other13D/A0.00%0 shares–Below 5%Aug 14, 2025SEC
Jul 9, 20255:21 PM ETGlazer Capital, LLCand 1 other13G7.30%2.53M sharesNewJul 2, 2025SEC
Feb 14, 20259:44 AM ETPrice T Rowe Associates Inc13G/A10.50%3.57M shares+10.30 ppfrom 0.20%Dec 31, 2024SEC
Feb 7, 202511:55 AM ETPrice T Rowe Associates Inc13G/A0.20%65.9K shares–Below 5%Jan 31, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell IGM Biosciences, Inc. shares.

No Form 144 notices for IGM Biosciences, Inc. are on file.